Shares of LifeStance Health Group, Inc. (NASDAQ:LFST – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the eleven analysts that are currently covering the company, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold rating, six have assigned a buy rating and two have given a strong buy rating to the company. The average 1-year price target among brokerages that have issued a report on the stock in the last year is $9.75.
A number of equities research analysts have recently weighed in on the stock. BTIG Research boosted their price objective on shares of LifeStance Health Group from $11.00 to $12.00 and gave the stock a “buy” rating in a report on Friday, May 8th. Weiss Ratings restated a “hold (c-)” rating on shares of LifeStance Health Group in a report on Wednesday, May 27th. Barclays boosted their price objective on shares of LifeStance Health Group from $8.00 to $9.00 and gave the stock an “overweight” rating in a report on Friday, March 6th. The Goldman Sachs Group assumed coverage on shares of LifeStance Health Group in a report on Friday. They issued a “neutral” rating and a $9.00 price objective for the company. Finally, JPMorgan Chase & Co. boosted their price objective on shares of LifeStance Health Group from $8.00 to $9.00 and gave the stock a “neutral” rating in a report on Thursday, May 14th.
View Our Latest Stock Analysis on LFST
LifeStance Health Group Price Performance
LifeStance Health Group (NASDAQ:LFST – Get Free Report) last released its quarterly earnings results on Wednesday, May 6th. The company reported $0.04 EPS for the quarter, topping analysts’ consensus estimates of $0.01 by $0.03. LifeStance Health Group had a net margin of 1.55% and a return on equity of 1.56%. The business had revenue of $403.48 million during the quarter, compared to analysts’ expectations of $387.46 million. The company’s quarterly revenue was up 21.2% on a year-over-year basis. On average, analysts predict that LifeStance Health Group will post 0.12 EPS for the current fiscal year.
LifeStance Health Group announced that its Board of Directors has authorized a share buyback program on Wednesday, February 25th that allows the company to repurchase $100.00 million in shares. This repurchase authorization allows the company to purchase up to 3.6% of its stock through open market purchases. Stock repurchase programs are often an indication that the company’s board believes its stock is undervalued.
Insider Transactions at LifeStance Health Group
In other news, Director Eric Shuey sold 243,362 shares of the business’s stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $8.02, for a total value of $1,951,763.24. Following the completion of the sale, the director directly owned 867,562 shares in the company, valued at approximately $6,957,847.24. The trade was a 21.91% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Darren M. Black sold 5,899,661 shares of the business’s stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $8.02, for a total transaction of $47,315,281.22. Following the completion of the sale, the director owned 23,310,115 shares of the company’s stock, valued at approximately $186,947,122.30. The trade was a 20.20% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last ninety days, insiders sold 6,868,057 shares of company stock worth $55,048,226. 3.20% of the stock is currently owned by insiders.
Institutional Investors Weigh In On LifeStance Health Group
Several institutional investors have recently added to or reduced their stakes in the company. Assetmark Inc. boosted its position in LifeStance Health Group by 17.0% during the 1st quarter. Assetmark Inc. now owns 9,419 shares of the company’s stock valued at $60,000 after buying an additional 1,367 shares during the period. Park Edge Advisors LLC boosted its position in LifeStance Health Group by 14.4% during the 4th quarter. Park Edge Advisors LLC now owns 11,863 shares of the company’s stock valued at $84,000 after buying an additional 1,495 shares during the period. California State Teachers Retirement System boosted its position in LifeStance Health Group by 1.6% during the 4th quarter. California State Teachers Retirement System now owns 125,682 shares of the company’s stock valued at $885,000 after buying an additional 1,966 shares during the period. Vident Advisory LLC raised its position in LifeStance Health Group by 12.7% during the 2nd quarter. Vident Advisory LLC now owns 21,732 shares of the company’s stock valued at $112,000 after purchasing an additional 2,447 shares during the last quarter. Finally, Xponance LLC raised its position in LifeStance Health Group by 26.4% during the 4th quarter. Xponance LLC now owns 13,144 shares of the company’s stock valued at $93,000 after purchasing an additional 2,745 shares during the last quarter. Hedge funds and other institutional investors own 85.50% of the company’s stock.
About LifeStance Health Group
LifeStance Health Group (NASDAQ:LFST) is a leading provider of outpatient mental health services in the United States. Headquartered in New York City, the company operates a growing network of clinics that deliver integrated, patient-centered psychological and psychiatric care. LifeStance’s mission is to expand access to high-quality mental health treatment by combining evidence-based therapy modalities with personalized treatment plans.
The company’s service offerings include individual, family, and group psychotherapy, psychiatric medication management, psychological assessment, and telehealth services.
Read More
- Five stocks we like better than LifeStance Health Group
- Samsara Just Answered The AI Question—Is Wall Street Ready To Listen?
- IREN’s 800MW Bet Flips the AI Power Switch
- CrowdStrike Earnings Beat Sparks Selloff—Buy the Dip?
- Tesla’s EV Rebound Leaves Rivian and Lucid Facing a Tougher Investor Test
Receive News & Ratings for LifeStance Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeStance Health Group and related companies with MarketBeat.com's FREE daily email newsletter.
